SmokingNCT05471349
Message Testing in Older Adult Smokers
A study testing Flyer and video in people with Smoking and Smoking Cessation, run by University of Wisconsin, Madison at 1 site in United States.
Trial summary
This study is examining different messages to motivate older smokers to quit smoking. Participants will be current smokers, between the ages of 50-80 years old, who do not have a history of cognitive impairment or dementia. Participants can expect to take part in a one-time 30 minute online survey. Read more about this study
- Who is it for?
- Ages 50 to 80 years
- Conditions the study is for
- Smoking, Smoking Cessation
- What is being tested?
- Flyer and video
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 820 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Jul 2022to 18 Jul 2022
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Current smoker (smoking at least some days per week)
- Ability to read and write English
- Between the ages of 50 and 80 years old
Who cannot join
- History of Mild Cognitive Impairment or dementia
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Message Testing in Older Adult Smokers (MCAS-2)
This study is examining different messages to motivate older smokers to quit smoking. Participants will be current smokers, between the ages of 50-80 years old, who do not have a history of cognitive impairment or dementia. Participants can expect to take part in a one-time 30 minute online survey.
- Conditions
- Smoking, Smoking Cessation
- Being tested
- Flyer and video
- Medical subject headings
- Smoking, Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Flyer and videoBehavioural
Participants will view a flyer and video
| Study group | Role | What they receive |
|---|---|---|
| Hope message | Active comparator | Participants will view a hope-based video message and flyer. Receives: Behavioral: Flyer and video |
| Fear message | Active comparator | Participants will view a fear-based video message and flyer. Receives: Behavioral: Flyer and video |
| Control message | Placebo comparator | Participants will view a water advertisement video and flyer. Receives: Behavioral: Flyer and video |
What is being measured
The primary outcome is the main question the study is designed to answer.
Emotional Response
Measure participants' emotional response to the messages using a 1-9 scaled measurement of 14 different emotions (9 indicating more emotional response). Emotionality will be presented together summarizing the mean presentation of these emotions by the different groups.
Measured: Through study completion, approximately 30 minutes
Motivation to Quit
Measure participants' motivation to quit after viewing the flyer and video, using a 1 item scaled measurement of motivation to quit (1-7 scale, 7 indicating higher motivation).
Measured: Through study completion, approximately 30 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jul 2022
- Study start12 Jul 2022
- Primary completion18 Jul 2022
- Study completion18 Jul 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for SmokingStudies of the same condition, open and under way.
- More trials run by University of Wisconsin, MadisonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 820 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Wisconsin, Madison
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Aging (NIA), Centiment LLC
- Responsible party
- Sponsor
- Investigators
- Adrienne Johnson, PhD, Principal investigator, University of Wisconsin, Madison
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05471349
- Sponsor's protocol ID
- 2022-0624
- Other IDs
- 1K23AG067929-01A1, 2022-0624, A534253, SMPH/MEDICINE/GEN INT MD
- Status last verified
- Jan 2024
- First submitted
- 20 Jul 2022
- Last updated
- 31 Jan 2024
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jan 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Message Testing in Older Adult Smokers (MCAS-2)
- ClinicalTrials.gov ID
- NCT05471349
- Acronym / sponsor ID
- 2022-0624
- Conditions
- Smoking, Smoking Cessation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 820 participants (actual)
- Lead sponsor
- University of Wisconsin, MadisonUniversity, hospital or other
- Collaborators
- National Institute on Aging (NIA), Centiment LLC
- Study start
- 12 Jul 2022 (actual)
- Primary completion
- 18 Jul 2022 (actual)
- Study completion
- 18 Jul 2022 (actual)
- First posted
- 22 Jul 2022 (actual)
- Results
- Posted 31 Jan 2024
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is examining different messages to motivate older smokers to quit smoking. Participants will be current smokers, between the ages of 50-80 years old, who do not have a history of cognitive impairment or dementia. Participants can expect to take part in a one-time 30 minute online survey.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Hope message | Active comparator | Behavioral: Flyer and videoParticipants will view a hope-based video message and flyer. |
| Fear message | Active comparator | Behavioral: Flyer and videoParticipants will view a fear-based video message and flyer. |
| Control message | Placebo comparator | Behavioral: Flyer and videoParticipants will view a water advertisement video and flyer. |
Who may qualify
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Current smoker (smoking at least some days per week)
- Ability to read and write English
- Between the ages of 50 and 80 years old
Key exclusion criteria (1 listed)
- History of Mild Cognitive Impairment or dementia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Flyer and videoParticipants will view a flyer and video | Behavioural | Control message, Fear message, Hope message |
Primary outcome
Emotional Response
Time frame: Through study completion, approximately 30 minutes
Measure participants' emotional response to the messages using a 1-9 scaled measurement of 14 different emotions (9 indicating more emotional response). Emotionality will be presented together summarizing the mean presentation of these emotions by the different groups.
Motivation to Quit
Time frame: Through study completion, approximately 30 minutes
Measure participants' motivation to quit after viewing the flyer and video, using a 1 item scaled measurement of motivation to quit (1-7 scale, 7 indicating higher motivation).
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jan 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Smoking
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Recruiting
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
Physician's Role, Smoking Cessation
RecruitingPhase 3
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Recruiting
Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in Kuwait
Lung Cancer, Lung Neoplasms
Active, not recruitingPhase 4
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
Smoking Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Adrienne Johnson, PhD principal investigator
University of Wisconsin, Madison
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Flyer and video in people with Smoking and Smoking Cessation, run by University of Wisconsin, Madison at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 31 Jan 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Emotional Response (time frame: Through study completion, approximately 30 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2024.